Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE.

Alexander BM, Ba S, Berger MS, Berry DA, Cavenee WK, Chang SM, Cloughesy TF, Jiang T, Khasraw M, Li W, Mittman R, Poste GH, Wen PY, Yung WKA, Barker AD; GBM AGILE Network.

Clin Cancer Res. 2018 Feb 15;24(4):737-743. doi: 10.1158/1078-0432.CCR-17-0764. Epub 2017 Aug 16. Review.

PMID:
28814435
2.

Prioritization schema for immunotherapy clinical trials in glioblastoma.

Hodges TR, Ferguson SD, Caruso HG, Kohanbash G, Zhou S, Cloughesy TF, Berger MS, Poste GH, Khasraw M, Ba S, Jiang T, Mikkelson T, Yung WK, de Groot JF, Fine H, Cantley LC, Mellinghoff IK, Mitchell DA, Okada H, Heimberger AB.

Oncoimmunology. 2016 Feb 18;5(6):e1145332. doi: 10.1080/2162402X.2016.1145332. eCollection 2016 Jun. Review.

3.

Sharing publication-related data and materials: responsibilities of authorship in the life sciences.

Cech TR, Eddy SR, Eisenberg D, Hersey K, Holtzman SH, Poste GH, Raikhel NV, Scheller RH, Singer DB, Waltham MC; National Academics Committee on Responsibilities of Authorship in the Biological Sciences.

Plant Physiol. 2003 May;132(1):19-24. No abstract available.

4.

Parkinson's disease: prospects for improved drug therapy.

Hagan JJ, Middlemiss DN, Sharpe PC, Poste GH.

Trends Pharmacol Sci. 1997 May;18(5):156-63. Review.

PMID:
9184476
5.

Synthesis of cell coat in normal and transformed cells.

Mallucci L, Poste GH, Wells V.

Nat New Biol. 1972 Feb 16;235(59):222-3. No abstract available.

PMID:
4334932

Supplemental Content

Loading ...
Support Center